These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33402820)

  • 1. Risk of Pneumonia Associated with Inhaled Corticosteroid in Patients with Chronic Obstructive Pulmonary Disease: A Korean Population-Based Study.
    Lee JH; Park YH; Kang DR; Lee SJ; Lee MK; Kim SH; Yong SJ; Lee WY
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3397-3406. PubMed ID: 33402820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study.
    Choi JH; Jeong KB; Park YH; Yu I; Lee SJ; Lee MK; Kim SH; Lee WY; Yong SJ; Lee JH
    Int J Chron Obstruct Pulmon Dis; 2021; 16():3229-3237. PubMed ID: 34858023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial.
    Tashkin DP; Miravitlles M; Celli BR; Metzdorf N; Mueller A; Halpin DMG; Anzueto A
    Respir Res; 2018 Oct; 19(1):196. PubMed ID: 30290801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study.
    Wang CY; Lai CC; Yang WC; Lin CC; Chen L; Wang HC; Yu CJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2775-2783. PubMed ID: 27877031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled corticosteroid use in patients with chronic obstructive pulmonary disease and the risk of pneumonia: a retrospective claims data analysis.
    Yawn BP; Li Y; Tian H; Zhang J; Arcona S; Kahler KH
    Int J Chron Obstruct Pulmon Dis; 2013; 8():295-304. PubMed ID: 23836970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies.
    Lodise TP; Li J; Gandhi HN; O'Brien G; Sethi S
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2889-2900. PubMed ID: 33204085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Safety and Effectiveness of Inhaled Corticosteroid and Long-Acting β
    Chang TY; Chien JY; Wu CH; Dong YH; Lin FJ
    Chest; 2020 May; 157(5):1117-1129. PubMed ID: 31887282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD.
    Wu MF; Jian ZH; Huang JY; Jan CF; Nfor ON; Jhang KM; Ku WY; Ho CC; Lung CC; Pan HH; Wu MC; Liaw YP
    BMC Cancer; 2016 Oct; 16(1):778. PubMed ID: 27724847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts.
    Lee SH; Lee JH; Yoon HI; Park HY; Kim TH; Yoo KH; Oh YM; Jung KS; Lee SD; Lee SW
    Respir Res; 2019 Mar; 20(1):62. PubMed ID: 30922302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort study.
    DiSantostefano RL; Sampson T; Le HV; Hinds D; Davis KJ; Bakerly ND
    PLoS One; 2014; 9(5):e97149. PubMed ID: 24878543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety.
    Suissa S; Dell'Aniello S; Ernst P
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1975-1986. PubMed ID: 36065315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.
    Sonnappa S; Martin R; Israel E; Postma D; van Aalderen W; Burden A; Usmani OS; Price DB;
    PLoS One; 2017; 12(6):e0178112. PubMed ID: 28617814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled corticosteroids in COPD and the risk of lung cancer.
    Lee YM; Kim SJ; Lee JH; Ha E
    Int J Cancer; 2018 Nov; 143(9):2311-2318. PubMed ID: 29943812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High versus Medium Dose of Inhaled Corticosteroid in Chronic Obstructive Lung Disease: A Systematic Review and Meta-Analysis.
    Archontakis Barakakis P; Tran T; You JY; Hernandez Romero GJ; Gidwani V; Martinez FJ; Fortis S
    Int J Chron Obstruct Pulmon Dis; 2023; 18():469-482. PubMed ID: 37056683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled corticosteroids have a protective effect against lung cancer in female patients with chronic obstructive pulmonary disease: a nationwide population-based cohort study.
    Liu SF; Kuo HC; Lin MC; Ho SC; Tu ML; Chen YM; Chen YC; Fang WF; Wang CC; Liu GH
    Oncotarget; 2017 May; 8(18):29711-29721. PubMed ID: 28412726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials.
    Yang M; Du Y; Chen H; Jiang D; Xu Z
    Int Immunopharmacol; 2019 Dec; 77():105950. PubMed ID: 31629940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study.
    Bloom CI; Douglas I; Usmani OS; Quint JK
    Int J Chron Obstruct Pulmon Dis; 2020; 15():701-710. PubMed ID: 32308379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled Corticosteroid-Related Tuberculosis in the Real World Among Patients with Asthma and COPD: A 10-Year Nationwide Population-Based Study.
    Lee CM; Heo J; Han SS; Moon KW; Lee SH; Kim YJ; Lee SJ; Kwon JW
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1197-1206.e3. PubMed ID: 30339858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study.
    Morjaria JB; Rigby A; Morice AH
    Lung; 2017 Jun; 195(3):281-288. PubMed ID: 28255905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.